Gut Microbiota Predict Efficacy of Neoadjuvant Systemic Therapy in Patients with Early Breast Cancer

被引:0
|
作者
Ross, K. [1 ]
Nichols, B. [1 ]
Papadopoulou, R. [1 ]
Macleod, M. [2 ]
Fraser, J. [2 ]
Barrett, S. [2 ]
Teo, K. [3 ]
Mallon, E. [3 ]
Ammar, A. [1 ]
Edwards, J. [1 ]
Evans, J. [1 ,2 ]
Gerasimidis, K. [1 ]
Macpherson, I. [1 ,2 ]
机构
[1] Univ Glasgow, Glasgow, Lanark, Scotland
[2] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[3] NHS Greater Glasgow & Clyde, Glasgow, Lanark, Scotland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E107 / E108
页数:2
相关论文
共 50 条
  • [31] Development of a predictive model utilizing the neutrophil to lymphocyte ratio to predict neoadjuvant chemotherapy efficacy in early breast cancer patients
    Zhu, Jiujun
    Jiao, Dechuang
    Zhao, Yajie
    Guo, Xuhui
    Yang, Yue
    Xiao, Hui
    Liu, Zhenzhen
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [32] Development of a predictive model utilizing the neutrophil to lymphocyte ratio to predict neoadjuvant chemotherapy efficacy in early breast cancer patients
    Jiujun Zhu
    Dechuang Jiao
    Yajie Zhao
    Xuhui Guo
    Yue Yang
    Hui Xiao
    Zhenzhen Liu
    Scientific Reports, 11
  • [33] Gut microbiota interact with breast cancer therapeutics to modulate efficacy
    Arnone, Alana A.
    Ansley, Katherine
    Heeke, Arielle L.
    Howard-McNatt, Marissa
    Cook, Katherine L.
    EMBO MOLECULAR MEDICINE, 2025, 17 (02) : 219 - 234
  • [34] Omission of breast surgery in selected breast cancer patients with excellent response to neoadjuvant systemic therapy
    Tasoulis, Marios-Konstantinos
    Muktar, Samantha
    Smith, Ian
    Roche, Nicola
    Macneill, Fiona
    EJSO, 2024, 50 (06):
  • [35] The efficacy of screening with FDG-PET/CT for distant metastases in breast cancer patients scheduled for neoadjuvant systemic therapy
    Gunster, Jetske L. B.
    van Duijnhoven, Frederieke H.
    Scholten, Astrid N.
    Smorenburg, Carolien H.
    Dezentje, Vincent O.
    van Olmen, Josefien P.
    Marijnen, Corrie A. M.
    Stokkel, Marcel P. M.
    Loo, Claudette E.
    Schrijver, A. Marjolein
    BREAST CANCER RESEARCH AND TREATMENT, 2025, 209 (01) : 117 - 124
  • [36] Breast conserving therapy after neoadjuvant systemic therapy in patients with T3 breast cancer is feasible
    Van der Noordaa, M.
    Peeters, M. J. Vrancken
    Ioan, I.
    Loo, C.
    Van Urk, J.
    Voorthuis, R.
    Van Werkhoven, E.
    Wiersma, T.
    Dezentje, V.
    Groen, E.
    Rutgers, E.
    Van Duijnhoven, F.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S82 - S83
  • [37] Breast conserving therapy after neoadjuvant systemic therapy in patients with T3 breast cancer is feasible
    van der Noordaa, M. E.
    Peeters, M-J M. Vrancken
    Ioan, I.
    Loo, C. E.
    van Urk, J.
    van Werkhoven, E.
    Voorthuis, R.
    Wiersma, T.
    Groen, E.
    Rutgers, E. T.
    van Duijnhoven, F. H.
    CANCER RESEARCH, 2019, 79 (04)
  • [38] Neoadjuvant systemic therapy in geriatric breast cancer patients: a National Cancer Database (NCDB) analysis
    Brown, Lauren
    Naffouje, Samer A.
    Sam, Christine
    Laronga, Christine
    Lee, M. Catherine
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 196 (03) : 441 - 451
  • [39] Personalized circulating tumor DNA monitoring to predict response to neoadjuvant therapy in patients with early-stage breast cancer
    George, Mridula
    Meghal, Trishala
    Omene, Coral
    Kalashnikova, Ekaterina
    Fielder, Janie
    Ohri, Nisha
    Kumar, Shicha
    Burkovskaya, Valeria
    Patel, Preena
    Young, Ashley
    Racenstein, Melanie
    Bauman, Tinamarie
    Mchayleh, Wassim
    Toppmeyer, Deborah
    Ganesan, Shridar
    Rosen, Barry
    Rodriguez, Angel
    Liu, Minetta
    CANCER RESEARCH, 2024, 84 (09)
  • [40] Neoadjuvant systemic therapy in geriatric breast cancer patients: a National Cancer Database (NCDB) analysis
    Lauren Brown
    Samer A. Naffouje
    Christine Sam
    Christine Laronga
    M. Catherine Lee
    Breast Cancer Research and Treatment, 2022, 196 : 441 - 451